Advertisement
Home »

ECZTRA 6 Phase 3 Randomized Trial Supports Tralokinumab for Adolescent Moderate-to-Severe Atopic Dermatitis

Apr 30, 2023

ABOUT THE EXPERTS

Advertisement
Advertisement